Microfluidic Devices Market in the Healthcare Industry to 2015

2013-01-22
Published : Jan-2013

TechNavio”s analysts forecast the Global Microfluidic Devices market in the Healthcare industry to grow at a CAGR of 26.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing use of microfluidic devices in proteomics and genomics. The Global Microfluidic Devices market in the Healthcare industry has also been witnessing the trend of the increasing use of microfluidic devices in drug discovery. However, the intense competition among vendors could pose a challenge to the growth of this market.

TechNavio”s report, the Global Microfluidic Devices Market in the Healthcare Industry 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Monoclonal Antibodies market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Fluidigm Corp., RainDance Technologies Inc., Agilent Technologies Inc., and Dolomite Centre Ltd.

The other vendors mentioned in the report are Micronit Microfluidics BV, Illumina Inc., MicruX Technologies Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, BioFluidix GmbH, Abaxis Inc., Advion Biosciences Inc., Caliper Life Sciences Inc., Cepheid Inc., Danaher Corp., Eksigent Technologies Inc., GE Novasensor Inc., Illumina Inc., Johnson and Johnson, Konica Minolta Holdings Inc., Microfluidic Systems Inc., Life Technologies Corp., Philips Healthcare, Roche Diagnostics, Shimadzu Biotech, and Siemens Healthcare.

Key questions answered in this report:
What will the market size be in 2015 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio”s research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=212064.

Table of Contents

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
Market Size and Forecast
04.1 Market Segmentation by Application
04.2 Five Forces Analysis
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and Their Impact
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Key Vendor Analysis
12.1 Fluidigm Corp.
Business Overview
Key Information
SWOT Analysis
12.2 RainDance Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.3 Agilent Technologies Inc.
Business Overview
Key Information
SWOT Analysis
12.4 Dolomite Centre Ltd.
Business Overview
Key Information
SWOT Analysis
13. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Microfluidic Devices Market in the Healthcare Industry 2011-2015 (US$ million)
Exhibit 2: Global Microfluidic Devices Market in the Healthcare Industry Segmentation by Application 2011
Exhibit 3: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in percent)
Exhibit 4: Global Microfluidic Devices Market in the Healthcare Industry Segmentation 2011-2015 (in US$ million)
Exhibit 5: Global Microfluidic Devices Market in the Healthcare Industry by Vendor Segmentation (by revenue) 2011

Contact sales@reportsandreports.com for further information.

Filed in: Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Brazil

Brazil has one of the fastest growing pharmaceutical markets in the world. It is driven by an increasing disease burden and high affordability. However, a decrease in foreign investment and increased government promotion of generic drugs are barriers to growth. The value of the market was US$25.3 Billion in 2016, having increased from US$15.4 Billion in 2009 at a Compound Annual Growth Rate (CAGR) of 3.4%. Changing demographics are an important driver for the market, as the increasingly elderly population will lead to an increase in the incidence of chronic and other lifestyle-associated diseases. The growing middle class, who have high purchasing power, is another major driver. Brazil's medical device market was valued at US$7.1 Billion in 2009 and US$9.7 Billion in 2016. It is project......
$1995

Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

Global consumers are becoming more health-conscious as a reaction to rising obesity levels and lifestyle-related illnesses, such as diabetes, in the modern world. Consumers' busy lives are a major driver for the healthcare and OTC market as people opt for more convenient, multifunctional, and personalized products that better target their specific needs. Over-the-counter (OTC) drugs are those sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription. The pressures of modern life are taking their toll on consumers as their increasingly hectic lifestyles, due to work, active social lives and family responsibilities, means that stress is the most concerning hea......
$3450

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. Data prese......
$1000

Arterial Stiffness Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Arterial Stiffness Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Stiffness clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Stiffness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clini......
$2500

Arterial Thrombosis Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Arterial Thrombosis Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different cl......
$2500

Arteriosclerosis Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Arteriosclerosis Global Clinical Trials Review, H1, 2017" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical tr......
$2500

Arteriovenous Fistula Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Arteriovenous Fistula Global Clinical Trials Review, H1, 2017" provides an overview of Arteriovenous Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriovenous Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ differ......
$2500

Artery Stenosis Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Artery Stenosis Global Clinical Trials Review, H1, 2017" provides an overview of Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Artery Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial......
$2500

Arthralgia Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Arthralgia Global Clinical Trials Review, H1, 2017" provides an overview of Arthralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Arthralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, co......
$2500

Articular Cartilage Defect Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, "Articular Cartilage Defect Global Clinical Trials Review, H1, 2017" provides an overview of Articular Cartilage Defect clinical trials scenario. This report provides top line data relating to the clinical trials on Articular Cartilage Defect. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated ......
$2500